CDTI Innovación and the ERDF funds drive Inmunotek’s new therapies against dust mite allergy

by CDTI Innovación

Reducing treatment duration, improving patient adherence, and changing the course of allergic disease caused by house dust mites are the goals of the new generation of vaccines developed by Inmunotek ...

Read more

El FAIIP, gestionado por SEPIDES, ha aprobado un nuevo proyecto por valor de 1,79 millones de euros

by SEPIDES

INMUNOTEK, S.L. es un laboratorio farmacéutico especializado en la fabricación y comercialización de vacunas y productos sanitarios para el tratamiento de alergias y enfermedades relacionadas con e...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

MATX and BerriUp Join Forces to Mobilise...

by BerriUp

Under this framework, MATX and BerriUp will work together to identify ...

Photos Stream